0000000001092866

AUTHOR

J. De Groot

showing 7 related works from this author

Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2021

BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduces risk for AIDS and non-AIDS-related events in asymptomatic, HIV-positive persons and is the standard of care. However, most HIV-positive persons initiate ART when their CD4 count decreases below 500 × 10 9 cells/L. Consequences of delayed ART on risk for non-AIDS-defining and AIDS-defining cancer, one of the most common reasons for death in HIV, are unclear. OBJECTIVE: To estimate the long-term risk difference for cancer with the immediate ART strategy.DESIGN: Multinational prospective cohort study.SETTING: The D:A:D (Data collection on Adverse events of anti-HIV Drugs) study, which included…

MaleHIV AIDSHIV Infections0302 clinical medicineInterquartile rangeRisk FactorsNeoplasmsMedicine030212 general & internal medicineProspective StudiesProspective cohort study0303 health sciencesIncidenceAbsolute risk reductionDrugsGeneral MedicineMiddle AgedViral LoadAntiretroviral therapy3. Good healthAIDSCancer treatmentPrevention policy and public healthCohortInfectious diseasesCohort studiesFemaleViral loadAdultmedicine.medical_specialtyAnti-HIV AgentsHIV Infections/drug therapySocio-culturaleTime-to-Treatment03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)SDG 3 - Good Health and Well-beingInternal medicineInternal MedicineHumansAdverse effect030306 microbiologybusiness.industryHIVCancermedicine.diseaseCD4 Lymphocyte CountCancer.Anti-HIV Agents/therapeutic use[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessNeoplasms/epidemiologyAnnals of Internal Medicine
researchProduct

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

2020

Abstract Background High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed …

Male0301 basic medicinePsychological interventionHuman immunodeficiency virus (HIV)MedizinContinuum of care; Europe; HIV infection; Key population; Sex; Anti-Retroviral Agents; Continuity of Patient Care; European Union; HIV; Humans; Male; HIV InfectionsHIV InfectionsContinuum of care; Europe; HIV infection; Key population; Sexmedicine.disease_causekey population0302 clinical medicineContinuum of careHIV Infection030212 general & internal medicineMen having sex with menContinuum of caremedia_commoneducation.field_of_study[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTransmission (medicine)Continuity of Patient CareEuropeInfectious DiseasesAcademicSubjects/MED00290Anti-Retroviral AgentsHIV infection continuum of care sex key population EuropeSexMicrobiology (medical)PopulationSocio-culturale03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)SDG 3 - Good Health and Well-beingmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unioneducationPandemicsHIV infection ; continuum of care ; sex ; key population ; Europebusiness.industrySARS-CoV-2COVID-19HIVmedicine.diseaseHIV infectioncontinuum of care030112 virologyMajor Articles and CommentariesKey populationAnti-Retroviral Agentbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

Alignment of the ALICE Inner Tracking System with cosmic-ray tracks

2010

ALICE (A Large Ion Collider Experiment) is the LHC (Large Hadron Collider) experiment devoted to investigating the strongly interacting matter created in nucleus-nucleus collisions at the LHC energies. The ALICE ITS, Inner Tracking System, consists of six cylindrical layers of silicon detectors with three different technologies; in the outward direction: two layers of pixel detectors, two layers each of drift, and strip detectors. The number of parameters to be determined in the spatial alignment of the 2198 sensor modules of the ITS is about 13,000. The target alignment precision is well below 10 micron in some cases (pixels). The sources of alignment information include survey measurement…

Physics - Instrumentation and DetectorsPhysics::Instrumentation and DetectorsperspectiveHigh Energy PhisicsDetector alignment and calibration methods (lasers sources particle-beams); Particle tracking detectors (Solid-state detectors); Instrumentation; Mathematical Physics01 natural sciences7. Clean energylaw.inventionHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)lawParticle tracking detectors[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Tracking detectors; High Energy Phisics; Heavy Ion PhysicsDetectors and Experimental TechniquesDetector alignment and calibration methodsNuclear ExperimentInstrumentationphysics.ins-detMathematical PhysicsdetectorsPhysicsLarge Hadron ColliderSolenoidal vector fieldPhysicsDetectorInstrumentation and Detectors (physics.ins-det)particle-beams)collisionsParticle tracking detectors (Solid-state detectors) ; Detector alignment and calibration methods (lasers ; sources ; particle-beams)collaboration; collisions; detector alignment and calibration methods (lasers; sources; particle-beams); detectors; particle tracking detectors (solid-state detectors); performance; perspective; quark-gluon plasmaColliding beam accelerators collisions Pb-Pb collisionsParticle tracking detectors (Solid-state detectors); Detector alignment and calibration methods (lasers sources particle-beams); QUARK-GLUON PLASMAperformancesourcesquark-gluon plasmaDetector alignment and calibration methodFOS: Physical sciencesCosmic ray114 Physical sciencesNuclear physicsTracking detectorsOpticsparticle tracking detectors (solid-state detectors)0103 physical sciences[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsColliderPixel010308 nuclear & particles physicsbusiness.industryhep-exHeavy Ion Physicsdetector alignment and calibration methods (laserscollaborationQuark–gluon plasmaDetector alignment and calibration methods; Particle tracking detectorsALICE (propellant)business
researchProduct

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Resear…

2021

Abstract Background Epidemiological studies in atrial fibrillation (AF) illustrate that clinical complexity increase the risk of major adverse outcomes. We aimed to describe European AF patients’ clinical phenotypes and analyse the differential clinical course. Methods We performed a hierarchical cluster analysis based on Ward’s Method and Squared Euclidean Distance using 22 clinical binary variables, identifying the optimal number of clusters. We investigated differences in clinical management, use of healthcare resources and outcomes in a cohort of European AF patients from a Europe-wide observational registry. Results A total of 9363 were available for this analysis. We identified three …

RegistrieResearch Reportmedicine.medical_specialtyMajor adverse outcomeCardiovascular risk factorsCluster analysisRisk FactorsInternal medicineClinical phenotypeAtrial FibrillationEpidemiologyHumansMedicineRegistriesCluster analysiAtrial fibrillation; Clinical management; Clinical phenotypes; Cluster analysis; Major adverse outcomes; Humans; Phenotype; Registries; Research Report; Risk Factors; Atrial FibrillationClinical managementbusiness.industryProportional hazards modelRisk FactorHazard ratioRAtrial fibrillationClinical phenotypesMajor adverse outcomesGeneral Medicinemedicine.diseaseAtrial fibrillationConfidence intervalPhenotypeCohortMedicineObservational studybusinessResearch ArticleHumanBMC Medicine
researchProduct

Two-pion Bose-Einstein correlations inppcollisions ats=900  GeV

2010

We report on the measurement of two-pion correlation functions from pp collisions at root s = 900 GeV performed by the ALICE experiment at the Large Hadron Collider. Our analysis shows an increase of the Hanbury Brown-Twiss radius with increasing event multiplicity, in line with other measurements done in particle- and nuclear collisions. Conversely, the strong decrease of the radius with increasing transverse momentum, as observed at the Relativistic Heavy Ion Collider and at Tevatron, is not manifest in our data.

PhysicsNuclear and High Energy PhysicsParticle physicsLarge Hadron ColliderMeson010308 nuclear & particles physicsNuclear TheoryHadronTevatronParticle acceleratorBose–Einstein correlations01 natural scienceslaw.inventionNuclear physicsPionlaw0103 physical sciencesHigh Energy Physics::ExperimentNuclear Experiment010306 general physicsRelativistic Heavy Ion ColliderPhysical Review D
researchProduct

Midrapidity Antiproton-to-Proton Ratio inppCollisons ats=0.9and 7 TeV Measured by the ALICE Experiment

2010

The ratio of the yields of antiprotons to protons in pp collisions has been measured by the ALICE experiment at root s = 0.9 and 7 TeV during the initial running periods of the Large Hadron Collider. The measurement covers the transverse momentum interval 0.45 < p(t) < 1.05 GeV/c and rapidity vertical bar y vertical bar < 0.5. The ratio is measured to be R-vertical bar y vertical bar<0.5 = 0.957 +/- 0.006(stat) +/- 0.0014(syst) at 0.9 Tev and R-vertical bar y vertical bar<0.5 = 0.991 +/- 0.005 +/- 0.014(syst) at 7 TeV and it is independent of both rapidity and transverse momentum. The results are consistent with the conventional model of baryon-number transport and set stringent limits on a…

PhysicsParticle physicsLarge Hadron ColliderProton010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyHadronGeneral Physics and Astronomy01 natural sciences7. Clean energyParticle identificationBaryonNuclear physicsAntiproton0103 physical sciencesHigh Energy Physics::ExperimentRapidityNuclear Experiment010306 general physicsBar (unit)Physical Review Letters
researchProduct

The ALICE Collaboration

2009

The production of mesons containing strange quarks (KS, φ) and both singly and doubly strange baryons ( , , and − + +) are measured at mid-rapidity in pp collisions at √ s = 0.9 TeV with the ALICE experiment at the LHC. The results are obtained from the analysis of about 250 k minimum bias events recorded in 2009. Measurements of yields (dN/dy) and transverse momentum spectra at mid-rapidity for inelastic pp collisions are presented. For mesons, we report yields (〈dN/dy〉) of 0.184 ± 0.002(stat.) ± 0.006(syst.) for KS and 0.021 ± 0.004(stat.) ± 0.003(syst.) for φ. For baryons, we find 〈dN/dy〉 = 0.048 ± 0.001(stat.) ± 0.004(syst.) for , 0.047 ± 0.002(stat.) ± 0.005(syst.) for and 0.0101 ± 0.0…

PhysicsStrange quarkNuclear and High Energy PhysicsLarge Hadron ColliderMeson010308 nuclear & particles physics7. Clean energy01 natural sciencesSpectral lineVisual artsNuclear physicsBaryonMinimum biasTransverse momentum0103 physical sciencesHigh Energy Physics::ExperimentAstrophysics::Earth and Planetary AstrophysicsALICE (propellant)Nuclear Experiment010306 general physics
researchProduct